glp 1 approved for mash CDSCO Clears Wegovy — India's First GLP-1 Approval for Liver Disease, India's drug regulator CDSCO Novo Nordisk's Wegovy (semaglutide 2.4mg) on 17 July 2026 for MASH, based on Exploring the Potential of GLP-1
Pay in 4 interest-free payments of $5.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4




:max_bytes(150000):strip_icc()/VWH-Wegovy-receives-FDA-approval-for-treating-MASH-51d3bd1a89894b5e80b8a1a093d30a63.jpg)





















